Universe Pharmaceuticals INC

Universe Pharmaceuticals INC (UPC) priced its initial public offering on Mar 24, 2021 at $5.00 per share, within its $5.00–$7.00 range, raising $25M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $105M. Hunter Taubman Fischer & Li, Ogier and AllBright advised the company and Pryor Cashman advised the underwriters.

Universe Pharmaceuticals INC is a pharmaceutical company based in Jiangxi, China, that manufactures, markets, sells and distributes traditional Chinese medicine derivative products aimed at elderly people dealing with aging-related conditions and general well-being. It has registered and obtained approval for 26 products.

Status

IPO

Ticker

UPC

Exchange

Nasdaq Global Market

Priced

Mar 24, 2021

IPO price

$5.00

Price range

$5.00–$7.00

Raised

$25M

Market cap at IPO price

$105M

First filed

Aug 17, 2020

Company counsel

Hunter Taubman Fischer & Li, Ogier and AllBright

Underwriters' counsel

Pryor Cashman

Sector

Biotech & pharma

Country / state

China

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.